Clinical Trial Versus Real-World Outcomes With Anti-VEGF Therapy for Central Retinal Vein Occlusion

被引：0
|
作者：
Bhisitkul, Robert B. [1 ]
Blotner, Steven [2 ]
Steffen, Verena [2 ]
Haskova, Zdenka [2 ]
机构：
[1] Univ Calif San Francisco, Ophthalmol, San Francisco, CA 94143 USA
[2] Genentech Inc, San Francisco, CA 94080 USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2020年 / 61卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
1304
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Outcomes of quarterly anti-VEGF dosing for nAMD management in real-world clinical practice
    Rusakevich, Alexander Michael
    Zhou, Brenda
    Wykoff, Charles Clifton
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [32] Long-Term Outcomes in Early versus Limited Response to Anti-VEGF Treatment for Retinal Vein Occlusion
    Kailar, Roshni S.
    Kuo, Blanche L.
    Perkins, Scott W.
    Singh, Rishi P.
    OPHTHALMOLOGY, 2024, 131 (02) : 131 - 131
  • [33] Long-Term Outcomes in Early versus Limited Response to Anti-VEGF Treatment for Retinal Vein Occlusion
    Kailar, Roshni S.
    Kuo, Blanche L.
    Perkins, Scott W.
    Singh, Rishi P.
    OPHTHALMOLOGY RETINA, 2024, 8 (01): : 55 - 61
  • [34] Treatment discontinuation patterns of anti-VEGF in retinal vein occlusion
    Basilious, Amy
    Duncan, Julie
    Smuck, Bobbi
    Malvankar-Mehta, Monali S.
    Juncal, Verena R.
    Hooper, Phil
    Sheidow, Tom G.
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2024, 59 (05): : 341 - 349
  • [35] Real-life study of the use of anti-VEGF therapy versus dexamethasone implant for treatment of macular edema in retinal vein occlusion
    Manuel Casselholm de Salles
    David Epstein
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2021, 259 : 2653 - 2660
  • [36] Real-life study of the use of anti-VEGF therapy versus dexamethasone implant for treatment of macular edema in retinal vein occlusion
    de Salles, Manuel Casselholm
    Epstein, David
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2021, 259 (09) : 2653 - 2660
  • [37] Retinal blood flow following treatment of ischemic central retinal vein occlusion with anti-VEGF therapy and pan-retinal photocoagulation
    Matsumoto, Makiko
    Suzuma, Kiyoshi
    Tsuiki, Eiko
    Kitaoka, Takashi
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [38] Impact of Time to anti-VEGF Intervention on Visual Outcomes for Patients Diagnosed with Retinal Vein Occlusion
    Hsueh, Jessica
    Wai, Karen
    Conti, Felipe
    Singh, Rishi P.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [39] Age-related differences in presentation and outcomes of anti-VEGF treatment of retinal vein occlusion
    Dewan, Karan S.
    Hentati, Firas
    Greenlee, Tyler E.
    Conti, Thais F.
    Chen, Andrew X.
    Hom, Grant L.
    Singh, Rishi P.
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2021, 56 (02): : 96 - 104
  • [40] Intravitreal anti-VEGF monotherapy vs intravitreal anti-VEGF combined with low dose triamcinolone (2 mg) in central retinal vein occlusion
    Mudri, Joel
    Khan, Jane
    Perera, Chandrashan
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2019, 47 : 142 - 142
12345